Debut Plus

₹1,174

▼ -31.34 -2.60%

18 Jul 2026

NSE Listed · Healthcare

Entero Healthcare Solu Limited (ENTERO)

Volume: 53,396Avg Vol 1W: 41,090Avg Vol 1M: 36,09952W Range:₹944₹1,390
NSE BSE www.enterohealthcare.com
Key Ratios
Checked just now
Market Cap₹5,114 Cr
Current Price₹1,174
Previous Close₹1,205.34
High / Low (52w)₹1,390 / ₹944
Volume53,396
Avg Vol (1W)41,090
Avg Vol (1M)36,099
Stock P/E182.3
Book Value₹387.98
Dividend Yield0%
ROE6.81%
ROA405.08%
Revenue (TTM)—
Revenue Growth29.92%
Profit Margin174.54%
Total Debt₹0 Cr
Shares Outstanding4 Cr
Face Value₹10
EPS (TTM)₹27.69
P/B3.03
Debt / Equity0.22
50 DMA₹1,171.48
200 DMA₹1,168.35
Day change-2.60%
Price Chart
₹1,174▲ 10.77% · 1Y
₹1354₹94923.9L
2025-11-25
2026-07-17

20-day avg volume: 35K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 30% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 182.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1,097 Cr₹1,301 Cr₹1,359 Cr₹1,339 Cr₹1,404 Cr₹1,571 Cr₹1,707 Cr₹1,910 Cr
EBITDA₹37 Cr₹46 Cr₹49 Cr₹48 Cr₹47 Cr₹57 Cr₹63 Cr₹75 Cr
Net Profit₹20 Cr₹24 Cr₹25 Cr₹26 Cr₹28 Cr₹32 Cr₹28 Cr₹28 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹1,354 Cr₹1,784 Cr₹2,527 Cr₹3,306 Cr₹3,937 Cr₹5,135 Cr
EBITDA₹17 Cr₹9 Cr₹9 Cr₹45 Cr₹101 Cr₹180 Cr
Net Profit₹1 Cr₹-16 Cr₹-30 Cr₹-12 Cr₹39 Cr₹95 Cr
EPS0.02-0.3-191.9-0.1810.8121.76
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹749 Cr₹836 Cr₹1,126 Cr₹1,309 Cr₹2,345 Cr₹2,703 Cr
Total Liabilities₹325 Cr₹349 Cr₹563 Cr₹711 Cr₹704 Cr₹932 Cr
Equity₹424 Cr₹487 Cr₹563 Cr₹598 Cr₹1,641 Cr₹1,770 Cr
Total Debt——————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-32 Cr₹-64 Cr₹-24 Cr₹-33 Cr₹-24 Cr₹-39 Cr
Investing₹-203 Cr₹-31 Cr₹-162 Cr₹-49 Cr₹-705 Cr₹220 Cr
Financing₹217 Cr₹89 Cr₹211 Cr₹73 Cr₹863 Cr₹-74 Cr
Free Cash Flow₹-32 Cr₹-64 Cr₹-24 Cr₹-33 Cr₹-24 Cr₹-39 Cr
Shareholding
Promoter 52.42% Institutions 20.65% Public 26.93%
Efficiency & Working Capital
ROCE9.7%
Interest Coverage4.3
Dividend Payout—
Debtor Days59 d
Inventory Days47 d
Payable Days28 d
Cash Conversion Cycle78 d
Working Capital Days107 d
Shareholding Details

As of 2026-03-31

Promoter52.4%
FII4%
DII16.6%
Institutions20.7%
Public26.9%
Promoter Pledge0%
No. of Shareholders39,083
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Feb 2024Feb 2024Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters78.8%52.4%52.4%52.4%52.4%52.4%52.4%52.4%52.4%52.4%52.4%52.4%
FIIs0%22.8%22.8%23.3%23.3%23.8%22.2%19.9%17.2%14.7%5.1%4%
DIIs0%2.2%1.4%2.3%2.1%7.7%8.8%9.6%10.2%9.6%16.4%16.6%
Public21.2%22.6%23.4%22%22.2%16%16.6%18%20.2%23.3%26%26.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders511,14,2601,14,26080,86466,40036,76733,17233,15933,33836,33440,33239,083
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Orbimed Asia Iii Mauritius LimitedShareholding of Promoter and Promoter Group38%1.65 Cr
Surbhi Singh(prasid Uno Family Trust)Public Shareholding10.5%45,50,320
Prabhat AgrawalShareholding of Promoter and Promoter Group9.3%40,28,395
Prem SethiShareholding of Promoter and Promoter Group5.2%22,39,842
Icici Prudential Value FundPublic Shareholding4.8%20,97,962
Invesco India Aggressive Hybrid FundPublic Shareholding4.4%18,93,088
Cif Iii Scheme IPublic Shareholding2%8,48,060
Csim India Opportunities Fund 1Public Shareholding1.1%4,85,000
Persistence Capital Fund IPublic Shareholding1%4,36,583
Technomax InfosolutionsShareholding of Promoter and Promoter Group0%0
Uquifa Sciences Mascarene Ltd MauritiusShareholding of Promoter and Promoter Group0%0
Uquifa Sciences Uk LtdShareholding of Promoter and Promoter Group0%0
Uquifa Sciences Slu SpainShareholding of Promoter and Promoter Group0%0
Union Quimico Farmaceutica Sau SpainShareholding of Promoter and Promoter Group0%0
Uquifa Mexico Sa MexicoShareholding of Promoter and Promoter Group0%0
Holliday International LtdShareholding of Promoter and Promoter Group0%0
Soneas Chemicals HungaryShareholding of Promoter and Promoter Group0%0
Uquifa India LimitedShareholding of Promoter and Promoter Group0%0
Orbimed Asia Partners Iii, L.p.Shareholding of Promoter and Promoter Group0%0
Richa AgarwalShareholding of Promoter and Promoter Group0%300
Arti MittalShareholding of Promoter and Promoter Group0%143
Payal AgrawalShareholding of Promoter and Promoter Group0%0
Kunjbehari Lal AgrawalShareholding of Promoter and Promoter Group0%0
Asha AgrawalShareholding of Promoter and Promoter Group0%0
Neha AgrawalShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Prabhat Agrawal00%2026-03-31
Prem Sethi00%2026-03-31
Richa Agarwal00%2026-03-31
Arti Mittal00%2026-03-31
Payal Agrawal00%2026-03-31
Kunjbehari Lal Agrawal00%2026-03-31
Asha Agrawal00%2026-03-31
Neha Agrawal00%2026-03-31
Jaibhagwan Mittal00%2026-03-31
Komal Gupta00%2026-03-31
Kunal Mittal00%2026-03-31
Vikas Sethi00%2026-03-31
Board of Directors
NameDesignationYear
Sujesh VasudevanChairman & Independent Director2025
Prabhat AgrawalED / MD / CEO / Promoter2025
Prem SethiED / WTD / CFO / Promoter2025
Rajesh Shashikant DalalIndependent Non Exe. Director2025
SANDHYA SHARMAIndependent Non Exe. Director2025
Arun SadhanandhamNon Independent Non Executive Director / Nominee2025
Kevin Rohitbhai DaftaryNon Independent Non Executive Director / Nominee2025
Sumona ChakrabortyNon Independent Non Executive Director / Nominee2025
SANU VISHAL KAPOORVP / Company Secretary / Compliance Officer2025
Segments — Product
SegmentRevenueShare
Trading of Pharmaceutical and Surgi₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10754344
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20253,219001003,229
20251,26100001,261
20251,70300901,712
Insider / Designated-Person Trades

3 recent disclosure(s)

Jayant PrakashDisposal · 2,179
Jayant PrakashDisposal · 1,350
Abhitsh KumarDisposal · 1,200
Substantial Acquisitions (SAST)

13 disclosure(s)

Market29/12/2025 · 22,77,083
Market29/12/2025 · 21,82,039
Market11/08/2025 · 9,846
Market23/01/2025 · 1,03,982
Market09/01/2025 · 31,596
Release of Shares01/10/2024 · —
Company Information
Incorporated2018
ChairmanSujesh Vasudevan
AuditorMSKA & Associates
Investor Email[email protected]
🌐 www.enterohealthcare.com ↗

📍 Plot # I-35 Bldg-B Ind. Area, Phase-I 13/7 Mathura Road, Faridabad, Haryana, 121003

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Energy Deve. Co.LtdEnfuse Solutions LimitedEngineers India Ltd.Entertain Net. Ind. Ltd.Siemens Energy India Ltd.Enser Communications Ltd.Envirotech Systems Ltd.Epack Durable LimitedEPack Prefab Techn Ltd.Epigral LimitedEPL LimitedEPW India LimitedAll “E” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search